Ultrastructural myocardial changes produced by viruses

Recent Advances in Studies on Cardiac Structure and Metabolism
|January 1, 1975
PubMed

Insights

Picornavirus infections cause ultrastructural changes in heart muscle, including necrosis and viral crystals. These changes resemble those seen in human rheumatic heart disease, offering a model for viral cardiomyopathy research.

Area of Science:

  • Cardiology
  • Virology
  • Pathology

Background:

  • Viral infections, particularly picornaviruses, are known to cause myocardial damage.
  • Ultrastructural changes in the heart due to viral infections are not fully understood.
  • Rheumatic heart disease has characteristic myocardial and valvular alterations.

Purpose of the Study:

  • To describe ultrastructural pathological alterations in the myocardium caused by picornavirus infections.
  • To investigate the potential resemblance between viral-induced myocardial changes and rheumatic heart disease.
  • To establish a model for studying the natural history of viral cardiomyopathy.

Main Methods:

  • Electron microscopy was used to examine myocardial tissue from animals infected with picornaviruses.
  • Light microscopy was employed for comparison with electron microscopy findings.
  • Comparative analysis of ultrastructural findings in infected animals and human rheumatic heart disease.

Main Results:

  • Viral infections induced a spectrum of myocardial alterations, ranging from mild to severe necrosis.
  • Identifiable viral crystals were frequently observed in myocardial lesions of animals infected with Coxsackie B1 and EMC viruses.
  • Electron microscopy revealed early myocardial changes not detectable by light microscopy.

Conclusions:

  • Picornavirus infections induce significant ultrastructural myocardial pathology, including necrosis and viral inclusions.
  • The observed ultrastructural changes in viral-infected hearts closely mimic those found in human rheumatic heart disease.
  • This study provides a valuable animal model for investigating the pathogenesis of viral cardiomyopathy and its relationship to rheumatic heart disease.

Related Concept Videos

Layers of the Heart Wall01:15

Layers of the Heart Wall

The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...